(19)
(11) EP 1 080 203 A2

(12)

(88) Date of publication A3:
06.04.2000

(43) Date of publication:
07.03.2001 Bulletin 2001/10

(21) Application number: 99953359.9

(22) Date of filing: 28.05.1999
(51) International Patent Classification (IPC)7C12N 15/55, C12N 15/56, C12N 9/24, C12N 9/80, C12N 9/82, C07K 16/40, C12Q 1/68, A61K 38/47, A61K 38/50
(86) International application number:
PCT/US9912/021
(87) International publication number:
WO 9961/626 (02.12.1999 Gazette 1999/48)
(84) Designated Contracting States:
BE DE ES FR GB IT NL

(30) Priority: 29.05.1998 US 87236 P

(71) Applicant: INCYTE PHARMACEUTICALS, INC.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • BANDMAN, Olga
    Mountain View, CA 94043 (US)
  • HILLMAN, Jennifer, L.
    Mountain View, CA 94040 (US)
  • YUE, Henry
    Sunnyvale, CA 94087 (US)
  • LAL, Preeti
    Santa Clara, CA 95054 (US)
  • CORLEY, Neil, C.
    Mountain View, CA 94040 (US)
  • GUEGLER, Karl, J.
    Menlo Park, CA 94025 (US)
  • PATTERSON, Chandra
    Menlo Park, CA 94025 (US)
  • BAUGHN, Mariah, R.
    San Leandro, CA 94577 (US)

(74) Representative: Wright, Simon Mark 
J.A. Kemp & Co.14 South SquareGray's Inn
London WC1R 5LX
London WC1R 5LX (GB)

   


(54) HUMAN HYDROLASE HOMOLOGS: N-TERMINAL ASPARAGINE AMIDOHYDROLASE, GLYCOSYL HYDROLASE, GLUCOHYDROLASE, BIOTINIDASE, AND N-ACETYLGLUCOSAMINE 6-P DEACETYLASE